Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Eckerle

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Public Health|January 13, 2025
Epidemiological analysis and potential factors affecting the 2022-23 Crimean-Congo hemorrhagic fever outbreak in IraqChiori Kodama, Riyadh Abdulameer Alhilfi, Ihab Aakef, et al.
The Journal of Infectious Diseases|August 14, 2025
Diagnostic performance and kinetics of hepatitis E viral RNA and IgM antibody test positivity in a genotype 1 outbreak in South SudanAybüke Koyuncu, Robin Nesbitt, Catia Alvarez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceJavier Perez-Saez, María-Eugenia Zaballa, Sabine Yerly, et al.
Journal of Clinical Medicine|April 30, 2021
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence SettingsDiego O Andrey, Sabine Yerly, Benjamin Meyer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2021
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfectionPauline Vetter, Samuel Cordey, Manuel Schibler, et al.
Nature Communications|July 5, 2022
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsMeriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
Emerging Infectious Diseases|May 21, 2020
Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic ContaminationRamona Mögling, Adam Meijer, Natasa Berginc, et al.
Nature Communications|July 17, 2025
Evolving infectious disease dynamics shape school-based intervention effectivenessJavier Perez-Saez, Mathilde Bellon, Justin Lessler, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2021
Molecular epidemiology of respiratory syncytial virus in children in sub-Saharan AfricaClara Marlene Ihling, Paul Schnitzler, Norbert Heinrich, et al.
The Lancet. Infectious Diseases|January 11, 2025
The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case-control and bias indicator studyRobin C Nesbitt, Vincent Kinya Asilaza, Catia Alvarez, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Public Health|January 13, 2025
Epidemiological analysis and potential factors affecting the 2022-23 Crimean-Congo hemorrhagic fever outbreak in IraqChiori Kodama, Riyadh Abdulameer Alhilfi, Ihab Aakef, et al.
The Journal of Infectious Diseases|August 14, 2025
Diagnostic performance and kinetics of hepatitis E viral RNA and IgM antibody test positivity in a genotype 1 outbreak in South SudanAybüke Koyuncu, Robin Nesbitt, Catia Alvarez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceJavier Perez-Saez, María-Eugenia Zaballa, Sabine Yerly, et al.
Journal of Clinical Medicine|April 30, 2021
Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence SettingsDiego O Andrey, Sabine Yerly, Benjamin Meyer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2021
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfectionPauline Vetter, Samuel Cordey, Manuel Schibler, et al.
Nature Communications|July 5, 2022
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsMeriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
Emerging Infectious Diseases|May 21, 2020
Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic ContaminationRamona Mögling, Adam Meijer, Natasa Berginc, et al.
Nature Communications|July 17, 2025
Evolving infectious disease dynamics shape school-based intervention effectivenessJavier Perez-Saez, Mathilde Bellon, Justin Lessler, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2021
Molecular epidemiology of respiratory syncytial virus in children in sub-Saharan AfricaClara Marlene Ihling, Paul Schnitzler, Norbert Heinrich, et al.
The Lancet. Infectious Diseases|January 11, 2025
The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case-control and bias indicator studyRobin C Nesbitt, Vincent Kinya Asilaza, Catia Alvarez, et al.
Pageof 10